DocGo (NASDAQ:DCGO) Lowered to "Neutral" Rating by BTIG Research

DocGo (NASDAQ:DCGO - Get Free Report) was downgraded by stock analysts at BTIG Research from a "buy" rating to a "neutral" rating in a research note issued on Friday, MarketBeat reports.

A number of other equities research analysts also recently issued reports on DCGO. Needham & Company LLC reissued a "buy" rating and set a $4.00 price target on shares of DocGo in a research report on Tuesday, April 8th. Deutsche Bank Aktiengesellschaft cut DocGo from a "buy" rating to a "hold" rating and decreased their target price for the stock from $5.00 to $2.85 in a report on Friday, February 28th. Finally, Stifel Nicolaus dropped their target price on shares of DocGo from $6.50 to $5.50 and set a "buy" rating for the company in a research report on Friday, February 28th. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $3.56.

DocGo Stock Up 3.8%

Shares of DCGO stock traded up $0.06 during trading hours on Friday, hitting $1.50. 3,161,892 shares of the company were exchanged, compared to its average volume of 783,732. The firm has a fifty day moving average of $2.48 and a 200 day moving average of $3.67. DocGo has a 1 year low of $1.35 and a 1 year high of $5.68. The firm has a market cap of $152.97 million, a PE ratio of 5.36, a PEG ratio of 14.16 and a beta of 1.14.

DocGo (NASDAQ:DCGO - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The company reported ($0.09) earnings per share for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.08). DocGo had a return on equity of 8.90% and a net margin of 4.35%. The company had revenue of $96.03 million for the quarter, compared to analysts' expectations of $104.25 million. Analysts expect that DocGo will post 0.25 earnings per share for the current year.

Institutional Investors Weigh In On DocGo

A number of large investors have recently modified their holdings of the stock. American Century Companies Inc. boosted its holdings in DocGo by 175.5% in the 1st quarter. American Century Companies Inc. now owns 1,245,894 shares of the company's stock worth $3,289,000 after acquiring an additional 793,640 shares during the period. Brandywine Global Investment Management LLC raised its stake in shares of DocGo by 12.0% during the first quarter. Brandywine Global Investment Management LLC now owns 77,269 shares of the company's stock valued at $204,000 after purchasing an additional 8,279 shares during the period. Russell Investments Group Ltd. lifted its position in shares of DocGo by 59.0% during the first quarter. Russell Investments Group Ltd. now owns 229,213 shares of the company's stock worth $605,000 after purchasing an additional 85,097 shares in the last quarter. Nuveen LLC acquired a new position in shares of DocGo during the first quarter worth $649,000. Finally, Jefferies Financial Group Inc. raised its position in shares of DocGo by 6,874.1% during the 1st quarter. Jefferies Financial Group Inc. now owns 2,029,456 shares of the company's stock worth $5,358,000 after purchasing an additional 2,000,356 shares during the period. Institutional investors and hedge funds own 56.44% of the company's stock.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.